The American Cancer Society estimates that in 2015, approximately 12,900 new cases of invasive cervical cancer will be diagnosed in the United States alone. To detect those cases, physicians use a Pap smear as the primary cervical cancer screening method.. However, a recent study published in the journal of Gynecologic Oncology, advocates for routine Human Papillomavirus (HPV) screening instead.
The study, authored by an expert panel from the Food and Drug Administration (FDA), found that testing for HPV is more beneficial for cervical cancer screening than a Pap smear alone. The authors claim that routine Pap testing, performed every three years, isn’t as beneficial and accurate as routine HPV testing.